14.07.20 ijBio Portfolio

14.07.20 ijBio Portfolio

Infojet Club

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 14.07.20:

AstraZeneca (AZN) $51,3 $54 (+5.3%) $105,300

Inovio (INO) $13,2 $26,2 (+98.5%) $198,500

Moderna (MRNA)$61,5 $75 (+21.9%) $121,900

Abbot (ABT) $88,5 $94,8 (+7,1%) $107,100

Gilead (GILD) $72,5.  $77,2 (+6.5%) $106,500

Adaptive (ADPT) $42,2.  $43,2 (+2.4%) $102,400

CytoDyn (CYDY) $3,12 $4,84 (+55.1%) $155,100

AbbVie (ABBV) $92,2 $98,9 (+7.3%) $107,300

Arcus (RCUS) $27,3 $23,4 (-14.3%) $85,700

Sorrento (SRNE) $4,6  $7,94 (+72,6%) $172,600

At close 14.07.20= $1,262,400 (+4,8%)

per million dollars at 10% per share.


previous day

At close 13.07.20= $ 1,204,500 (-1,6%)

At close 10.07.20= $ 1,224,200

during the week 03-10.06.2020: +0.5%

At close 02.07.20= $1,220,500

during the week 26-03.06.2020: -4.5%

At close 26.06.20= $1,279,600

during the week 19-26.06.2020:+21%

At close 19.06.20= $1,057,700

during the week 12-19.06 +5,5%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

FOREX-Riskier currencies gain on vaccine hopes; dollar hits one-month low

GLOBAL MARKETS-Asian shares gain in cautious mood as U.S.-China tensions rise

Moderna Soars 16% As Covid-19 Vaccine Shows Strong Immune Response

JGB yields edge higher on vaccine hopes; BOJ keeps monetary policy steady

FOREX-Euro hits 4-month high vs dollar on stimulus, recovery hopes

Results show Moderna COVID-19 vaccine is safe

GLOBAL MARKETS-Asian shares pare gains as U.S.-China tensions intensif

Clinical trial results indicate Moderna coronavirus vaccine is on the right track

5 Stock Gainers Tuesday: Rigel, Vaxart, Boeing, Nvidia and Moderna

Dow Jones Futures Rise On Moderna Coronavirus Vaccine News After Stock Market Rally; Tesla Gains On Cybertruck Tax Breaks

Japan stocks hit 5-week high on hopes of virus drug, economic growth

GLOBAL MARKETS-Asian markets, risk assets ride up on vaccine hopes

U.S. Stock Futures Rise on Positive Results for Moderna Vaccine

Moderna’s Covid Vaccine News Is Good. But Market-Moving Good?

Analyst Predicts Approval for Moderna’s COVID-19 Vaccine


Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us












Report Page